欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号AT/H/1295/003
药品名称Bosutinib Sandoz 500 mg film-coated tablets
活性成分
    • Bosutinib 500.0 mg
剂型Film-coated tablet
上市许可持有人Sandoz GmbH Biochemiestrasse 10 6250 Kundl, Austria
参考成员国 - 产品名称Austria (AT)
互认成员国 - 产品名称
    • Norway (NO)
    • Poland (PL)
      Bosutinib Sandoz
    • Hungary (HU)
    • Croatia (HR)
    • Denmark (DK)
      Bosutinib Sandoz
    • Belgium (BE)
      Bosutinib Sandoz 500 mg filmomhulde tabletten
    • Ireland (IE)
    • France (FR)
    • Italy (IT)
    • Sweden (SE)
许可日期2025/07/02
最近更新日期2025/08/06
药物ATC编码
    • L01EA04 bosutinib
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase